StockData

Amphastar Pharmaceuticals, Inc. (AMPH) stock

AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3013% below fair value
$29.17−0.20 (-0.68%)

Close on Nov 16, 2026Market cap $1.24BP/E 17.2Yield –

Amphastar Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Amphastar Pharmaceuticals's EV/EBITDA was 13.5× on Nov 11, 2026, against 10.8× a year earlier. Over the last 5 years it ranged from 7.0× to 21.2×, with a median of 11.5×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.5×+3.0
2025Dec 31, 202510.5×+2.3
2024Dec 31, 20248.2×−8.3
2023Dec 29, 202316.5×+4.7
2022Dec 30, 202211.9×−6.6
2021Dec 31, 202118.4×−39.2
2020Dec 31, 202057.6×−456.5
2019Dec 31, 2019514.1×+339.3
2017Oct 31, 2017174.8×+150.9
2016Dec 30, 201623.8×−0.7
2014Jul 31, 201424.5×–

More Amphastar Pharmaceuticals figures

See a number that looks wrong?